Related Experiment Video
Updated: Jun 23, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Medical treatment for stroke prevention
D B Matchar1, D C McCrory, H J Barnett
1Center for Health Policy Research and Education, Duke University, Durham, NC 27708.
Annals of Internal Medicine
|July 1, 1994
Summary
Medical treatments like warfarin and aspirin can prevent stroke in high-risk patients. Warfarin is best for nonvalvular atrial fibrillation, while aspirin is a safer alternative and first choice for TIA or minor stroke.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Stroke is a leading cause of death and disability.
- Identifying effective preventive treatments is crucial for high-risk populations.
Purpose of the Study:
- To review the effectiveness of medical treatments for stroke prevention.
- To evaluate anticoagulants and antiplatelet agents in various patient groups.
Main Methods:
- Systematic review of English-language articles published after 1977.
- Included randomized controlled trials indexed in MEDLINE.
- 33 relevant studies were selected and abstracted.
Main Results:
- Warfarin highly effective for nonvalvular atrial fibrillation, reducing stroke and death.
- Aspirin is less effective but safer than anticoagulation.
- Aspirin and ticlopidine reduce stroke risk in TIA or minor stroke patients.
- Warfarin effective post-myocardial infarction but with high complication rates; aspirin offers slight stroke risk reduction.
Conclusions:
- Warfarin recommended for nonvalvular atrial fibrillation with risk factors.
- Aspirin recommended for those at high bleeding risk or as a first-line treatment for TIA/minor stroke.
- Ticlopidine considered for aspirin-intolerant or non-responsive patients, or post-major stroke.
- Aspirin recommended for secondary myocardial infarction prevention, not stroke prevention in post-MI patients.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Stroke: Introduction and Types
A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.